Biolinerx Ltd.-Spons ADRBLRX
13F holders, Q1 2026 (March 31)13holders −1
1new positions
2sold out
$2.31avg. 13F price*
At the end of Q1 2026, 13 institutions reported holding Biolinerx Ltd.-Spons ADR (BLRX) in their 13F filings, down 1 from Q4 2025. 1 opened new positions and 2 sold out. The largest holders were XTX Topco Ltd ($25K), Rhumbline Advisers ($5K) and BNP Paribas Financial Markets ($4K).
- Company
- Biolinerx Ltd.-Spons ADR
- CUSIP
- 09071M304
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $25K |
| Exits | 2 | $104K |
All 13F filers, Q4 2025 → Q1 2026: 11,241 shares bought and 39,393 shares sold, net −28,152 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| XTX Topco Ltd | 0.00% | New | 10,941 | $25K |
| Rhumbline Advisers | 0.00% | Reduce -29.8% | 2,353 | $5K |
| BNP Paribas Financial Markets | 0.00% | Add +20.0% | 1,800 | $4K |
| Wells Fargo & Company | 0.00% | No change | 1,750 | $4K |
| Citigroup Inc. | 0.00% | Reduce -15.2% | 1,728 | $4K |
| UBS Group AG | 0.00% | Reduce -72.9% | 529 | $1K |
| Nemes Rush Group LLC | 0.00% | No change | 250 | $575 |
| NewEdge Advisors, LLC | 0.00% | No change | 107 | $247 |
| Morgan Stanley | 0.00% | No change | 100 | $230 |
| Osaic Holdings, Inc. | 0.00% | No change | 26 | $59 |
| Rockefeller Capital Management L.P. | 0.00% | No change | 12 | $28 |
| Danske Bank A/S | 0.00% | No change | 2 | $5 |
| Banque Cantonale Vaudoise | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is BLRX's weight in each manager's 13F, not the share of Biolinerx Ltd.-Spons ADR the manager owns.